Related Experiment Video

Updated: Jun 21, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: a molecular docking analysis

Caitlin E Cassidy1, William N Setzer

  • 1Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA.

Journal of Molecular Modeling
|July 16, 2009
PubMed

Insights

Cytotoxic prenylated flavonoids from Lonchocarpus haberi show strong binding to cancer targets like aromatase and fatty acid synthase. These natural compounds may exert anticancer effects by inhibiting key enzymes involved in cancer progression.

Area of Science:

  • Natural Product Chemistry
  • Medicinal Chemistry
  • Computational Biology

Background:

  • Flavonoids are known for their diverse biological activities, including anticancer properties.
  • Prenylated flavonoids, a subclass, often exhibit enhanced bioactivity.
  • Lonchocarpus haberi is a plant source of potentially bioactive flavonoids.

Purpose of the Study:

  • To investigate the molecular interactions of cytotoxic prenylated flavonoids from Lonchocarpus haberi with cancer-relevant targets.
  • To compare the binding affinities of these flavonoids with known inhibitors using molecular docking.
  • To explore the potential mechanisms of cytotoxic activity.

Main Methods:

  • Molecular docking simulations were performed using Molegro and ArgusDock software.
  • Binding energies were calculated for Lonchocarpus flavonoids against a panel of cancer-related enzymes.
  • Comparisons were made with known flavonoids and ligands.

Main Results:

  • Lonchocarpus flavonoids demonstrated docking energies comparable to or exceeding those of established inhibitors.
  • Prenylated flavonoids, including those from Lonchocarpus haberi, generally displayed stronger binding than non-prenylated analogs.
  • Significant binding was observed against targets such as aromatase (CYP 19), fatty acid synthase (FAS), and various kinases.

Conclusions:

  • The cytotoxic activity of Lonchocarpus flavonoids is likely mediated through the inhibition of one or more cancer-related enzymes.
  • Prenylation appears to enhance the binding affinity and potential efficacy of these flavonoids.
  • This study highlights the potential of Lonchocarpus flavonoids as leads for anticancer drug development.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...